(Q40835990)

24 September 2017

1 reference

title

Antibiotic resistance in community-acquired respiratory tract infections: current issues (English)

1 reference

24 September 2017

main subject

antibiotic resistance

1 reference

respiratory tract infection

inferred from title

1 reference

Spach DH

1 reference

24 September 2017

Black D

series ordinal

1 reference

24 September 2017

publication date

1 October 1998

1 reference

Annals of Allergy, Asthma & Immunology

24 September 2017

published in

1 reference

24 September 2017

1 reference

24 September 2017

1 reference

24 September 2017

page(s)

293-302; quiz 302-3

1 reference

Resistance to antimicrobial drugs--a worldwide calamity

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Emerging resistance to antibiotics: impact on respiratory infections in the outpatient setting

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Decline of erythromycin resistance of group A streptococci in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Multiply resistant pneumococcus causing meningitis: its epidemiology within a day-care centre

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Antibiotic-resistant pneumococci in hospitalized children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Hungary sees an improvement in penicillin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

beta-Lactamases in laboratory and clinical resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

An Enzyme from Bacteria able to Destroy Penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Bacterial resistance to aminoglycoside antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Penicillin-binding proteins and bacterial resistance to beta-lactams

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Trends in bacterial resistance to fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Impermeability to quinolones in gram-positive and gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Mechanisms of quinolone resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Active efflux mechanisms for antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Molecular mechanisms of resistance to trimethoprim.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

The clinical impact of resistance in the management of pneumococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Genetics and molecular biology of beta-lactam-resistant pneumococci.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

In vitro killing of penicillin-suseceptible, -intermediate, and -resistant strains of streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: A comparison of bactericidal and inhibitory activity with achievable CSF levels

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

The pneumococcal vaccine after 15 years of use.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Resistance to Erythromycin in Group A Streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Decline of erythromycin resistance of group A beta-hemolytic streptococci in Japan. Comparison with worldwide reports

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Haemophilus influenzae: then and now.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Is Haemophilus influenzae finished?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Phylogenetic Relationships between Some Members of the Genera Neisseria, Acinetobacter, Moraxella, and Kingella Based on Partial 16S Ribosomal DNA Sequence Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Branhamella catarrhalis as an indirect pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Antibiotic Prescribing for Children With Colds, Upper Respiratory Tract Infections, and Bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Impact of therapeutic guidelines on antibiotic use by residents in primary care clinics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

What will it take to stop physicians from prescribing antibiotics in acute bronchitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Treatment of acute bronchitis in adults without underlying lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Perspectives on chemotherapeutic approaches to antibiotic-resistant bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Epidemiology of drug resistance: implications for a post-antimicrobial era

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

Inactivation of antibiotics and the dissemination of resistance genes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

The role of fundamental research and biotechnology in finding solutions to the global problem of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963121-3

7 January 2021

10.1016/S1081-1206(10)63121-3

Identifiers

DOI

1 reference

24 September 2017

1 reference